Anouk Déruaz-Luyet (Anouk Luyet-Déruaz, Anouk Deruaz-Luyet)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Systematic Review

Top Venues

Diabetes, obesity & metabolism

Endocrinology, diabetes & metabolism

Clinical pharmacology and therapeutics

Current heart failure reports

This page only lists publications with an associated author ORCID identifier.

Publications

Grammati Sarri, Wei Liu, Luke Zabotka, Andreas Freitag, Ravinder Claire, Grace Wangge, Jamie Elvidge, Dalia M Dawoud, Dimitri Bennett, Xuerong Wen, Xiaojuan Li, Christopher T Rentsch, Md Jamal Uddin, M Sanni Ali, Mugdha Gokhale, Anouk Déruaz-Luyet, Daniela C Moga, Jeff Jianfei Guo, Andrew R Zullo, Elisabetta Patorno, Kueiyu Joshua Lin
Prognostic factors of COVID-19: an umbrella review endorsed by the International Society for Pharmacoepidemiology. Clinical pharmacology and therapeutics (2023)
Aurore Bergamasco, Anouk Déruaz-Luyet, Nicholas D Gollop, Yola Moride, Qing Qiao
Epidemiology of Asymptomatic Pre-heart Failure: a Systematic Review. Current heart failure reports 19 (3) (2022)
Elisabetta Patorno, Ajinkya Pawar, Deborah J Wexler, Robert J Glynn, Lily G Bessette, Julie M Paik, Mehdi Najafzadeh, Kimberly G Brodovicz, Anouk Déruaz-Luyet, Sebastian Schneeweiss
Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study. Diabetes, obesity & metabolism (2021)
Yutaka Seino, Dae-Jung Kim, Daisuke Yabe, Elise Chia-Hui Tan, Wook-Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement, Atsutaka Yasui, Wei-Yu Lei, Sunwoo Lee, Moe H Kyaw, Anouk Déruaz-Luyet, Kimberly G Brodovicz, Wayne Huey Herng Sheu, null null
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study. Endocrinology, diabetes & metabolism 4 (1) (2020)
Anouk Déruaz-Luyet, Christina Raabe, Elizabeth M Garry, Kimberly G Brodovicz, Lawrence A Lavery
Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014. Diabetes, obesity & metabolism 22 (7) (2020)
Elisabetta Patorno, Mehdi Najafzadeh, Ajinkya Pawar, Jessica M Franklin, Anouk Déruaz-Luyet, Kimberly G Brodovicz, Adrian J Santiago Ortiz, Lily G Bessette, Martin Kulldorff, Sebastian Schneeweiss
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care. Endocrinology, diabetes & metabolism 3 (1) (2019)